Hitoshi Okazawa Selected Research

Intellectual Disability (Idiocy)

1/2020	PQBP1, an intellectual disability causative gene, affects bone development and growth.
10/2018	The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.
10/2018	PQBP1, an intrinsically disordered/denatured protein at the crossroad of intellectual disability and neurodegenerative diseases.
1/2013	Sox2 transcriptionally regulates PQBP1, an intellectual disability-microcephaly causative gene, in neural stem progenitor cells.
10/2010	Drosophila PQBP1 regulates learning acquisition at projection neurons in aversive olfactory conditioning.
11/2009	Knock-down of PQBP1 impairs anxiety-related cognition in mouse.
4/2006	Expression of human PQBP-1 in Drosophila impairs long-term memory and induces abnormal courtship.
9/2005	PQBP-1 is expressed predominantly in the central nervous system during development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hitoshi Okazawa Research Topics

Disease

11	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 11/2005
11	Huntington Disease (Huntington's Disease) 10/2023 - 10/2003
11	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 03/2009
10	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 04/2024 - 05/2002
8	Intellectual Disability (Idiocy) 01/2020 - 09/2005
5	Cognitive Dysfunction 11/2021 - 01/2016
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2021 - 01/2018
3	Necrosis 04/2021 - 01/2020
3	Microcephaly 10/2018 - 09/2005
3	X-Linked Mental Retardation (Mental Retardation, X Linked) 04/2014 - 04/2012
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2021
2	Schizophrenia (Dementia Praecox) 01/2023 - 01/2022
2	Inflammation (Inflammations) 11/2021 - 01/2015
1	Neuroinflammatory Diseases 03/2024
1	Infections 11/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	Pathologic Processes 06/2022
1	Bites and Stings (Sting) 11/2021
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2019
1	Lissencephaly 01/2019
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Disease Progression 01/2015
1	Postmortem Changes (Adipocere) 01/2011
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2010
1	Learning Disabilities (Learning Disability) 10/2010
1	Seizures (Absence Seizure) 11/2005

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2003
14	polyglutamineIBA 01/2023 - 05/2002
9	HMGB1 Protein (HMG1)IBA 03/2024 - 11/2008
5	Ataxin-1IBA 04/2024 - 04/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2008
3	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2012
3	polyglutamine-binding protein 1IBA 11/2021 - 09/2005
3	PhosphoproteinsIBA 04/2021 - 01/2011
3	Amyloid (Amyloid Fibrils)IBA 04/2021 - 01/2018
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 11/2009
3	Amyloid beta-PeptidesIBA 01/2020 - 07/2015
2	AutoantibodiesIBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2020 - 07/2018
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2015 - 11/2011
2	Mutant Proteins (Protein, Mutant)IBA 01/2012 - 07/2010
2	HMGB ProteinsIBA 01/2012 - 11/2011
2	ProteomeIBA 11/2011 - 01/2011
1	CytokinesIBA 04/2024
1	Histones (Histone)IBA 04/2024
1	RNA Splicing FactorsIBA 04/2024
1	Messenger RNA (mRNA)IBA 11/2023
1	Replication Protein AIBA 10/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	neuroligin 1IBA 01/2023
1	neuroligin 2IBA 01/2023
1	PrionsIBA 01/2023
1	Intrinsically Disordered ProteinsIBA 06/2022
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2022
1	Tamoxifen FDA LinkGeneric 11/2021
1	InterferonsIBA 11/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2021
1	tau Proteins (tau Protein)IBA 11/2021
1	Complementary DNA (cDNA)IBA 11/2021
1	Serine (L-Serine)FDA Link 01/2020
1	Cadherins (E-Cadherin)IBA 01/2019
1	Cell Cycle ProteinsIBA 10/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	ProgranulinsIBA 01/2018
1	Protein AggregatesIBA 01/2017
1	Small Molecule LibrariesIBA 09/2016
1	Histidine (L-Histidine)FDA Link 09/2016
1	Monoclonal AntibodiesIBA 01/2016
1	PhosphopeptidesIBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Mitochondrial DNA (mtDNA)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 08/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 03/2012
1	Ataxin-7IBA 03/2012
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2011
1	Antisense OligonucleotidesIBA 11/2010
1	Vorinostat FDA Link 10/2010
1	Histone Deacetylase InhibitorsIBA 10/2010
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 07/2008
1	Small Interfering RNA (siRNA)IBA 01/2007
1	Kainic Acid (Kainate)IBA 11/2005
1	Caspase 3 (Caspase-3)IBA 11/2005
1	Cytochromes c (Cytochrome c)IBA 11/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2003

Therapy/Procedure

6	Therapeutics 04/2024 - 01/2017
1	Subcutaneous Injections 01/2016